The SEC is looking at Valeant’s ‘potentially misleading’ accounting practices By: MarketWatch May 24, 2016 at 14:25 PM EDT SEC focus is on non-GAAP financial measures. Read More >> Related Stocks: Senvest Capital Inc Valeant Pharmaceuticals International, Inc.